Markets
Borrow
Earn
Invest
Private
Security
Newsroom
More
Log In
Sign Up
Markets
Market Overview
Indices and commodities.
Digital Credit
Bitcoin treasury preferreds.
AI Stocks
The artificial intelligence theme.
Bitcoin Treasuries
Companies holding bitcoin.
Economy
Sectors, global markets and rates.
Popular Portfolios
13F filings, smart money.
Borrow
Borrow
Borrow USDT or USDC against your BTC without giving it up.
ReFi
Switch your bitcoin-backed loan and pay less interest.
Earn
Carry Trade
Borrow, invest, keep the spread.
Stock Dividends
Dividends from tokenized equities.
Invest
Private
Security
Newsroom
More
Company
About Us
Our leadership team, mission, and investors.
Whitepaper
Vision, purpose, and architecture behind Roxom.
Legal
Terms, privacy, and disclosures.
Resources
Help Center
Guides, FAQs & support.
Rulebook
Trading logic, platform rules, and fundamentals.
API Docs
Connect, authenticate, and build with our API.
Status
Current platform health and incidents.
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
1 BTC
=
- USD
BTC
SATS
Loading market data...
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
BL
BioLineRX Ltd
BLRX
Mkt Cap
$10.3M
Volume
12.24K
Next Earnings
November 23rd
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
BL
BLRX
BL
BioLineRX Ltd
BLRX
News
·
Glioblastoma Clinical Trial Landscape Expands: Over 200 Companies Advancing Next-Generation Therapies | DelveInsight
Mkt Cap
$10.0M
Volume
12.24K
Next Earnings
November 23rd
Chart
Earnings
News
About
Insider
Filings
Glioblastoma Clinical Trial Landscape Expands: Over 200 Companies Advancing Next-Generation Therapies | DelveInsight
Over 200 companies are advancing 220+ pipeline glioblastoma drugs across various clinical development stages. The pipeline is shifting from conventional chemotherapy toward targeted therapy, immunotherapy, and epigenetic approaches. Key candidates include Kazia Therapeutics' Paxalisib (Phase III), BPG Bio's BPM31510, and immunotherapy programs from Inovio Pharmaceuticals. Recent developments include Telix's first radiopharmaceutical therapy entering Phase III trials and multiple clinical collaborations announced in early 2026.
GlobeNewswire Inc. · Jun 16, 2026
BioLineRx (BLRX) Q1 2026 Earnings Transcript
BioLineRx reported Q1 2026 results with a net loss of $2.6 million versus net income of $5.1 million in Q1 2025. The company initiated a Phase I/IIa trial for GLIX1 in glioblastoma with first patient dosed at NYU Langone Health, supported by preclinical data showing dose-dependent tumor growth inhibition. APHEXDA royalty revenues increased to $0.5 million from $0.3 million as Ayrmid's sales grew to $2.5 million. The company ended the quarter with $17.4 million in cash, sufficient to fund operations into H1 2027.
The Motley Fool · May 29, 2026
BioLineRx to Report Third Quarter 2024 Results on November 25, 2024
BioLineRx, a commercial-stage biopharmaceutical company, announced that it will release its Q3 2024 financial results on November 25, 2024, and host a conference call the same day.
Benzinga · Nov 20, 2024
HC Wainwright & Co. Maintains Buy Rating for BioLine Rx: Here's What You Need To Know
HC Wainwright & Co. has decided to maintain its Buy rating of BioLine Rx (NASDAQ:BLRX) and raise its price target from $19.00 to $21.00. Shares of BioLine Rx are trading up 11.36% over the last 24 hours, at $1.96 per share. A move to $21.00 would account for a 971.43% increase from the current share price. About BioLine Rx BioLine Rx Ltd is a pre-commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in ...Full story available on Benzinga.com
Benzinga · Sep 15, 2023
Unity Software To Rally Around 60%? Here Are 10 Other Analyst Forecasts For Friday
B of A Securities raised the price target for Unity Software Inc. (NYSE: U) from $46 to $56. B of A Securities analyst Ryan Gee upgraded the stock from Neutral to Buy. Unity Software shares fell 3% to close at $35.71 on Thursday. Truist Securities boosted Vornado Realty Trust (NYSE: VNO) price target from $22 to $27. Truist Securities analyst Michael Lewis downgraded the stock from Buy to Hold. Vornado Realty Trust shares gained 2.9% to close at $25.24 on Thursday. Needham cut the price target for STAAR Surgical Company (NASDAQ: STAA) from $54 to $52. Needham analyst David Saxon maintained a Buy rating. STAAR Surgical shares fell 1.8% to $42.08 in pre-market trading. HC Wainwright & Co. raised the price target for BioLineRx Ltd. (NASDAQ: BLRX) ...
Benzinga · Sep 15, 2023
5 Penny Stocks To Watch Before Next Week; Time To Buy?
Penny stocks to watch before next week. The post 5 Penny Stocks To Watch Before Next Week; Time To Buy? appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
PennyStocks · May 25, 2023
Why Apyx Medical Shares Dipped Over 60%; Here Are 123 Biggest Movers From Yesterday
Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares jumped 156.2% to close at $0.2608 on Thursday after dipping 40% on Wednesday. Fast Radius received Bankruptcy court approval of first day motions related to the company's voluntary Chapter 11 petitions filed on November 7. SHF Holdings, Inc. (NASDAQ: SHFS) jumped 86.7% to close at $3.79 on Thursday. EpicQuest Education Group International Limited (NASDAQ: EEIQ) rose 72.1% to close at $1.79. Magnite, Inc. (NASDAQ: MGNI) shares surged 65.6% to close at $9.57 after the company reported better-than-expected Q3 results. TG Therapeutics, Inc. (NASDAQ: TGTX) jumped 63.4% to close at $8.43 following narrower-than-expected Q3 loss. Digital Turbine, Inc. (NASDAQ: APPS) shares climbed 60.9% to close at $17.33 after reporting upbeat Q2 earnings. Cosmos Holdings Inc. (NASDAQ: COSM) gained 57.5% to settle at $0.1150. Repay Holdings Corporation (NASDAQ: RPAY) climbed 50.7% to close at $6.60 after the company reported upbeat Q3 results. BioLife Solutions, Inc. (NASDAQ: BLFS) surged 42.8% to close at $24.70 after reporting Q3 results. Ebix, Inc. (NASDAQ: EBIX) jumped 42.1% to close at $22.78. Ebix reported third-quarter FY22 revenue growth of 35% year-on-year to $257.9 million. Auddia Inc. (NASDAQ: AUUD) rose 41.5% to settle at $1.50. Auddia recently reported the departure of its Chief Financial Officer Brian Hoff. WeTrade Group, Inc. (NASDAQ: WETG) surged 41% to close at $1.10. Versus Systems Inc. (NASDAQ: VS) gained 40.9% to settle at $3.00. Motorsport Games Inc. (NASDAQ: MSGM) gained 38.7% to close at $8.99. Motorsport Games announced completion of previously announced 1-for-10 reverse stock split. Lantronix, Inc. (NASDAQ: LTRX) climbed 38.5% to close at $5.32 after the company posted upbeat Q1 earnings and raised FY23 forecast. ShiftPixy, Inc. (NASDAQ: PIXY) gained 38.3% to settle at $12.21. Invitae Corporation (NYSE: NVTA) rose 36.4% to close at $3.11 after the company reported better-than-expected Q3 results and reduced 2022 cash burn guidance. PetIQ, Inc. (NASDAQ: PETQ) climbed 36.4% to close at $9.75 following Q3 results. Rackspace Technology, Inc. (NYSE: RXT) climbed 35.8% to close at $5.92 following upbeat quarterly results. Cardlytics, Inc. (NASDAQ: CDLX) gained 33.2% to close at $4.89. Evolv Technologies Holdings, Inc. (NASDAQ: EVLV) rose 32.6% to close at $3.50 after the company reported better-than-expected Q3 results and raised its FY22 guidance. Paymentus Holdings, Inc. (NYSE: PAY) climbed 32% to close at $11.68 after the company reported better-than-expected Q3 sales results. Redfin Corporation (NASDAQ: RDFN) gained 31.8% to close at $4.31 following Q3 results. Schmitt Industries, Inc. (NASDAQ: SMIT) gained 31.7% to close at $1.2250. Carvana Co. (NYSE: CVNA) gained 31.6% to close at $9.99. YETI Holdings, Inc. (NYSE: YETI) jumped 31.6% to close at $39.92 after the company reported better-than-expected Q3 EPS and sales results. Compass, Inc. (NYSE: COMP) gained 31.4% to close at $2.43. ZimVie Inc. (NASDAQ: ZIMV) climbed 31.3% to settle at $9.64 following strong quarterly earnings. Consumer Portfolio Services, Inc. (NASDAQ: CPSS) climbed 31.2% to close at $8.67 following Q3 results. Purple Innovation, Inc. (NASDAQ: PRPL) climbed 31.1% to close at $4.47 after the company reported better-than-expected Q3 results and raised its FY22 adjusted EBITDA guidance. Fair Isaac Corporation (NYSE: FICO) jumped 31.1% to settle at $581.78 after the company reported better-than-expected Q4 EPS and sales results. IGM Biosciences, Inc. (NASDAQ: IGMS) gained 30.4% to close at $20.93. RingCentral, Inc. (NYSE: RNG) climbed 30.1% to close at $36.90 after the company reported better-than-expected Q3 EPS and sales results. 2U, Inc. (NASDAQ: TWOU) gained 29.8% to close at $8.76. 2U recently reported better-than-expected Q3 sales results. Surgery Partners, Inc. (NASDAQ: SGRY) climbed 29.6% to close at $28.89. Surgery Partners recently posted Q3 adjusted EPS of $(0.02). Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) rose 29.6% to close at $8.36. Theseus Pharmaceuticals Director Carl Gordon bought a total of 192,000 shares at an average price of $5.21. Unity Software Inc. (NYSE: U) gained 29.4% to close at $27.82 after the company reported better-than-expected Q3 sales results and issued Q4 and FY22 sales guidance above estimates. BioXcel Therapeutics, Inc. (NASDAQ: BTAI) rose 29.3% to close at $14.75 following Q3 results. Stitch Fix, Inc. (NASDAQ: SFIX) climbed 28.3% to settle at $4.17. Wayfair ...
Benzinga · Nov 11, 2022
What Happened This Week: The Pound, The Dow, VIX And Even Meta React
Investing.com · Sep 24, 2022
Why KnowBe4 Shares Jumped Over 28%; Here Are 79 Biggest Movers From Yesterday
Gainers Ventoux CCM Acquisition Corp. (NASDAQ: VTAQ) shares jumped 54.6% to settle at $7.05 on Monday. Purple Innovation, Inc. (NASDAQ: PRPL) shares surged 39.4% to close at $3.89 after the company confirmed that it received an unsolicited, non-binding proposal from Coliseum Capital Management to acquire all of the outstanding capital stock of Purple for $4.35 per share. Troika Media Group, Inc. (NASDAQ: TRKA) gained 33.3% to close at $0.4021. BYND Cannasoft Enterprises Inc. (NASDAQ: BCAN) rose 32.5% to close at $2.95 after the company announced it has signed a share purchase agreement to acquire 100% ownership of Zigi Carmel Initiatives & Investments for $28 million in stock. KnowBe4, Inc. (NASDAQ: KNBE) gained 28.2% to close at $22.17 after the company confirmed it received a non-binding proposal from Vista Equity Partners Management to acquire all of the outstanding shares of the company for $24 per share. American Virtual Cloud Technologies, Inc. (NASDAQ: AVCT) gained 28.1% to close at $0.2370. Allakos Inc. (NASDAQ: ALLK) rose 27.5% to settle at $5.84 after the company priced an underwritten offering of roughly 29.88 million shares of common stock at $5.02 per share. Winc, Inc. (NYSE: WBEV) gained 26.8% to close at $0.90. Winc, last month, posted a Q2 loss of $0.32 per share Tiziana Life Sciences Ltd (NASDAQ: TLSA) rose 24.8% to close at $0.6862. Tiziana Life Sciences recently announced purchase of 29,318 common shares by Executive Chairman. Marpai, Inc. (NASDAQ: MRAI) gained 22.5% to settle at $1.17. AlerisLife Inc. (NASDAQ: ALR) jumped 19.8% to close at $1.33. AlerisLife announced the appointment of Heather Pereira as Senior Vice President, CFO and Treasurer. ShiftPixy, Inc. (NASDAQ: PIXY) jumped 19.5% to close at $24.12. Coeur Mining, Inc. (NYSE: CDE) gained 17.5% to close at $3.35. Coeur announced agreement to sell Southern Nevada Holdings for upfront cash consideration of $150 million, and deferred cash consideration of $50 million. Sharecare, Inc. (NASDAQ: SHCR) rose 17.4% to settle at $1.96 after the company received three-year Wellness and Health Promotion Accreditation by the National Committee for Quality Assurance for its lifestyle and disease management interventions. Mega Matrix Corp. (NYSE: MTMT) gained 16.7% to close at $1.40. Wix.com Ltd. (NYSE: WIX) jumped 15.7% to settle at $85.26 after Starboard Value disclosed a 9% active stake in the company. Mill City Ventures III, Ltd. (NASDAQ: MCVT) gained 14.7% to close at $2.11. Studio City International Holdings Limited (NYSE: MSC) surged 13.3% to settle at $2.04. Secoo Holding Limited (NASDAQ: SECO) rose 13.2% to settle at $0.3972. Aladdin Technology Group recently agreed to invest RMB1.3 million in the company. VEON Ltd. (NASDAQ: VEON) rose 13.1% to close at $0.4071 after dropping 18% on Friday. VEON Group’s consolidated revenue rose 3.1% year-on-year for ...
Benzinga · Sep 20, 2022
US Markets Turn Higher As Dow Jumps Over 100 Points
U.S. stocks traded higher in volatile trading toward the end of trading, with the Dow Jones gaining more than 100 points on Monday. The Dow traded up 0.42% to 30,951.15 while the NASDAQ rose 0.55% to 11,511.91. The S&P 500 also rose, gaining, 0.46% to 3,890.96. Also check this: US Stocks Fall to Two-Month Low Amid Higher Volatility Leading and Lagging Sectors Materials shares rose by 0.8% on Monday. Meanwhile, top gainers in the sector included Coeur Mining, Inc. (NYSE: CDE), up 13% and Glatfelter Corporation (NYSE: GLT) up 12%. In trading on Monday, health care shares fell by 1.3%. Top Headline The NAHB housing market index declined for the ninth consecutive month to 46 in September, compared to market expectations of 47. It was the lowest reading since May 2020. Equities Trading UP KnowBe4, Inc. (NASDAQ: KNBE) shares shot up 28% to $22.11 after the company confirmed it received a non-binding proposal from Vista Equity Partners Management to acquire all of the outstanding shares of the ...
Benzinga · Sep 19, 2022
Holdings
Open Orders (0)
Positions (0)
Order History
Dividends
Transfers
Log In
to start trading
BL
BLRX
BioLineRX Ltd
Buy
Sell
Market
Limit
Soon
BLRX
25%
50%
75%
Max
Pay with
—
Start Trading
Available Balance
0.00
Your Position
You don't own any BLRX yet.
Related Tickers
Earnings